Cells must respond to a constantly changing stream of chemical information. Neurotransmitters, hormones and lipids are released and removed in complex patterns over many different timescales. How G-protein signaling converts this dynamic temporal information into appropriate cellular responses depends on the kinetics of the transduction process. Fast transduction kinetics allows cells faithfully to follow agonist profiles and preserve temporal information, whereas slower response kinetics can be useful for filtering, integrating and mediating responses over long timescales.
Factors that control G-protein signaling kinetics should profoundly influence cellular responses to dynamic signals. A large family of mammalian 'regulators of G protein signaling' (RGS proteins) have been cloned and members of this family have been shown to attenuate signal strength in some assays [1] [2] [3] . Recent studies of K + channel activation and phototransduction suggest that RGS proteins may also function as potent regulators of signaling kinetics [4] [5] [6] . The surprise from these studies is the finding that RGS proteins can change the nature of the start and end of a signaling event, while leaving the intensity of the signal unchanged.
RGS proteins are GAPs for heterotrimeric G proteins
Which steps in the G-protein cycle control the activation and deactivation kinetics ( Figure 1a) ? Activation depends on the rate at which ligand-bound receptor catalyzes exchange of GDP for GTP on the Gα subunit. Following exchange, GTP-bound Gα dissociates, at least partially, from the receptor and Gβγ. The length of time that GαGTP and Gβγ can interact with effectors is determined by the rate at which Gα hydrolyzes GTP to GDP. Following hydrolysis, inactive GαGDP binds Gβγ with high affinity, and terminates Gβγ signaling. Intrinsic GTP hydrolysis for purified Gα subunits is much slower (~1-5 min -1 ) than the deactivation rates for some Gprotein-controlled processes, such as phototransduction [6] and ion channel activation [7] . This suggests that GTPase-activating proteins (GAPs), which speed up the hydrolysis of GTP by Gα, must be present.
RGS proteins were first identified in screens for negative regulators of yeast mating pheromone responses (Sst2) and Caenorhabditis elegans egg-laying behavior (Egl-10) [8, 9] . Sst2 and Egl-10 both contain a conserved RGS domain of 120 amino acids. A mammalian RGS protein, GAIP, was independently cloned in a two-hybrid screen for Gα iinteracting proteins [10] . Subsequently, over 15 mammalian genes have been identified that contain the conserved RGS domain (Figure 2) . In vitro biochemical studies showed that RGS proteins have GAP activity for Activity of RGS proteins. (a) Activation of GIRK channels: G-proteincoupled receptors (GPCRs) bind ligand and catalyze nucleotide exchange; free Gβγ then binds and activates GIRK channels. Deactivation of GIRK channels: Gα hydrolyzes GTP -this step is faster in the presence of RGS proteins -and GαGDP binds Gβγ, thereby terminating GIRK activation. (b) GAP activity alone is predicted to speed up deactivation rates and reduce the maximal signal amplitude (see trace on right). The experiments of Doupnik et al. [4] and Saitoh et al. [5] show that RGS proteins speed up both activation and deactivation rates without decreasing the level of steady-state activation (see trace on left). RGS proteins bind to Gα-GDPAlF 4 -, a structural analog of the GTPase transition state, much more tightly than they bind either GαGTP or GαGTPγS, suggesting that they speed up GTP hydrolysis by stabilizing the transition state. The crystal structure of RGS4 complexed to Gα-GDPAlF 4 -showed that the RGS domain folds into a compact four-helix bundle, with its highly conserved helix-loop residues contacting the Gα 'switch' regions [14] . The structure suggests that RGS proteins may decrease activity, not only by acting as GAPs, but also by competitively inhibiting effector binding to Gα switch regions.
Some degree of RGS specificity for different Gα proteins has emerged from in vitro GAP assays and binding studies ( Figure 2 ). Most RGS proteins that have been tested interact with Gα i and Gα o and exhibit GAP activity; only RGS2 has been shown not to interact with Gα i or Gα o . But specificity for Gα i subtypes has also been observed [10] . The best GAPs for Gα q among the RGS proteins tested are RGS2 and RGS4 [12, 15] . Several RGS proteins expressed in the retina accelerate GTP hydrolysis by transducin, the trimeric G protein that transduces signal from light-activated rhodopsin [16] [17] [18] . No RGS proteins have yet been found to interact with Gα s .
The lipid modification state of Gα at its amino terminus can influence the efficacy and specificity of its RGS protein interactions [19] , although there is no contact between the RGS domain of RGS4 and the amino terminus of Gα i1 in the crystal structure [14] . This raises the possibility that non-conserved parts of RGS proteins interact with Gα outside the switch regions. The amino terminus of an RGS protein is also likely to contain lipid-modification sites and/or membrane-association domains [20] . A wide range of interactions between RGS proteins, G proteins and the membrane could confer specificity and target RGS proteins to the Gαβγ complex or lipid microdomains.
It is not clear whether all RGS proteins are GAPs for Gα i , Gα q or Gα t . The RGS domains in axin and D-AKAP are less well conserved, and located at the amino terminus, unlike the RGS domains of most mammalian RGS proteins with known GAP activity [21, 22] . Many of the hydrophilic residues that contact Gα i and are required for GAP activity [13] are not conserved in these proteins, suggesting that they may have novel binding specificities or functions.
Kinetics of coupling to K + channels
Many G-protein-coupled receptors in brain and heart activate an inward rectifier K + channel -known as GIRK -through Gβγ (Figure 1a ) [7] . GIRK channels rapidly respond to G-protein signaling and provide a useful tool for following G-protein kinetics. In atrial myocytes, full deactivation of the GIRK current after removal of muscarinic agonist occurs in less than a second, much faster than the intrinsic GTP hydrolysis rate of Gα i . When the channels are expressed in heterologous systems such as Xenopus oocytes or tissue culture cells, GIRK currents deactivate slowly over tens of seconds, a rate comparable to the intrinsic GTP hydrolysis rate for Gα i . Co-expression of various RGS proteins -RGS1, 3, 4 or 8 -with GIRK channels and receptors in Xenopus oocytes has dramatic effects on deactivation kinetics, speeding up recovery 3-6-fold (Figure 1b) [4, 5] . This indicates that GTP hydrolysis, rather than intrinsic R314 Current Biology, Vol 8 No 9
Figure 2
Summary of the domain structure, the demonstrated Gα interactions, and known tissue expression patterns of cloned RGS proteins. Note that two different proteins have been referred to as RGS9 [18, 26] , and that the representations of RGS12, RGS14, axin and D-AKAP2 are not drawn to scale. GIRK channel kinetics, determines the timecourse of channel deactivation following agonist removal.
Mammalian RGS proteins
Unexpectedly, RGS co-expression was also found to increase GIRK activation rates (Figure 1b) [4, 5] . Indeed, in mammalian cell lines, RGS4 was found to enhance both activation and deactivation rates to levels similar to those observed in heart and neurons [4] . Is this explained by faster GTP hydrolysis? The time for activation to approach equilibrium is inversely related to the sum of the activation and deactivation rates, so increased GTPase rates as a result of RGS overexpression could shorten the time to reach equilibrium. Increasing the GTPase rate should, however, reduce the GαGTP:GαGDP ratio at equilibrium, reducing the maximal receptor-stimulated GIRK current (Figure 1b) .
Neither group reported any negative effect of RGS on the amplitude of GIRK activation [4, 5] . Even when nucleotide exchange rates are limited by low agonist concentrations, RGS still speeds up activation without reducing the steady-state GIRK current amplitude. It will be important to reconcile this finding with other results suggesting that RGS proteins greatly reduce the receptor activation of other effectors, such as MAP kinase [3] . It also will be important to determine if these results are unique for G-protein activation of GIRK channels, or whether RGS proteins regulate the kinetics of G-protein coupling to other effectors, such as Ca 2+ channels or phosphatidylinositol-3-kinase.
As RGS proteins speed up GIRK activation without decreasing the steady-state current, they must directly enhance an activation rate. How could RGS proteins increase activation rates? The rate-limiting step for activation of GIRK channels is not known, so there are a number of potential explanations. For example, RGS proteins could directly promote the exchange of GTP for bound GDP. Although no RGS protein has been shown to bind with high affinity to GαGDP or speed up steadystate nucleotide exchange of purified GαGDP, it has not been tested whether RGS proteins speed up receptorcatalyzed exchange through low-affinity interactions with GαGDP or Gαβγ. Alternatively, RGS proteins could facilitate GαGTP dissociation from the receptor, or prevent GαGTP reassociation, thereby enhancing potentially slow binding or unbinding steps.
There are other possibilities, for example RGS proteins may promote the stability of a signaling complex with fast activation kinetics. Phospholipase C (PLC) is both an effector of Gα q and a GAP for Gα q [23] . In a reconstituted system, PLC greatly enhances the rate of receptor-catalyzed GDP-GTP exchange. It has been suggested that this effect results from formation of a stable complex between receptor, G protein and PLC. Rapid GTP hydrolysis prevents the G protein from fully dissociating from the receptor, allowing the complex to avoid the slow step of G protein binding to receptor. For such a model to account for GIRK activation, it will be important to know if RGS proteins bind a receptor-GαGTP complex, and whether GIRK activation requires G protein dissociation from the receptor.
Lastly, RGS proteins could enhance Gβγ dissociation. GIRK channels are activated by Gβγ rather than Gα, so the effects of RGS proteins on GIRK activation must be explained in terms of the lifetime of available Gβγ. This is not straightforward, as it is not known whether Gβγ must fully dissociate from Gα to activate GIRKs [24] . There is evidence that GαGTP can still bind Gβγ, perhaps through the α-helical amino terminus of Gα [25] . If complete dissociation between GαGTP and Gβγ is required for effectors to bind Gβγ, then RGS proteins may act as positive regulators by forcing the dissociation of Gβγ from Gα and thus increasing the level of free Gβγ available for interaction with effectors. Such a pattern of binding will also have implications for the attenuation of signaling by RGS GAP activity: if RGS proteins act in this way, they should inhibit Gα signaling to a greater extent than Gβγ signaling. But RGS proteins potently inhibit G protein activation of the mitogen activated protein (MAP) kinase pathway [3] and the yeast mating response [8] , both of which require Gβγ. This is more consistent with RGS simply accelerating GTP hydrolysis and thus the conversion of Gα-GTP to Gα-GDP, which would compete with effectors for binding to Gβγ.
Physiological functions of RGS proteins
Although our biochemical understanding of RGS proteins has increased dramatically in recent years, we still know very little about the physiological functions of mammalian RGS proteins. Like their yeast and C. elegans counterparts, mammalian RGS proteins could potentially function as negative regulators of G-protein signaling. Because RGS proteins can inhibit receptor activation of effectors such as MAP kinases and PLC, mammalian RGS proteins could antagonize long-lasting signals (with timescales in the range minutes to hours) that control slow, and largely irreversible, cellular processes such as gene expression and cytoskeletal rearrangement.
Cells in the brain, retina and heart must respond to signals on a much faster timescale (milliseconds to seconds). As is the case for GIRK activation and phototransduction, RGS proteins may function less to reduce the magnitude of responses than to tune signaling kinetics by accelerating deactivation, and possibly also activation. By speeding up deactivation, RGS proteins can reduce the total response for short signals, and thereby greatly improve temporal resolution. For GIRKs, and possibly also other effectors, the ability of RGS proteins to speed up activation may be physiologically important. For example, rapid activation could be useful for generating robust cellular responses to very short-lived signals, such as neurotransmitter released from a single vesicle and quickly removed by diffusion, reuptake or inactivation. In cases where RGS proteins only have GAP activity, an abundance of receptors and G proteins could ensure effector activation even in the presence of RGS proteins. Thus, the primary effect of RGS proteins would be to speed up activation and deactivation kinetics.
RGS proteins could influence many physiological processes, so the regulation of RGS protein function should be an exciting area of future research. Potential mechanisms for regulating RGS proteins include lipid modification, membrane association, post-translational modification and interaction with other regulatory proteins. The existence of many RGS proteins may allow specific signals, even in the same cell, to be independently controlled by regulating the expression of individual RGS proteins. Striking patterns of RGS mRNA in the brain are consistent with highly regulated expression [26] . There are many scenarios in which we could imagine a role for regulated RGS expression, such as development, neuronal plasticity, desensitization, heart disease and adaptation to chronic drug administration. G-protein pathways transduce some mitogenic signals, so it is interesting to note that an RGS protein has been found to be up-regulated by p53 [27, 28] , a tumor suppressor protein thought in certain circumstances to put a brake on the cell cycle. Immortal tissue-culture cells, on the other hand, appear to have low levels of GAP activity. Down-regulation of RGS proteins could be one way in which the power of mitogenic signals is increased in cancer cells.
At present, the analysis of mammalian RGS protein function is limited to RGS overexpression experiments. A better understanding of the normal physiological roles for RGS proteins will require RGS gene 'knockout' mice and the development of tools for inhibiting RGS function. Such studies will help to determine the role(s) that RGS proteins play in controlling the kinetics and magnitude of G-protein signaling in different physiological contexts.
